Use of Pulsed Electromagnetic Fields in Treatment of Benign Prostatic Hypertrophy: Three Case Studies

Benign Prostatic Hypertrophy (BPH) is the most common benign urological condition in males. It is a progressive condition associated with aging, affecting over 80% by age 80 and can affect quality of life. While the exact cause is not fully known, hormones, metabolic alterations, inflammation and vascular flow may be contributing causes of BPH. Medical or surgical treatments are the standard of care for addressing associated Lower Urinary Tract Symptoms (LTUS) and erectile dysfunction associated with BPH, but each has risks and is not always effective. Pulsed Electromagnetic Field (PEMF) therapy is a noninvasive modality that has been shown to address some of the potential underlying contributing factors of BPH, including inflammation and microvascularity. Ultrasound has been shown to be an effective modality to evaluate inflammatory and microvascular changes in the prostate in addition to size. Here we present three case studies of males with known BPH and varying degrees of LTUS treated with PEMF for 30 days, utilizing ultrasound to evaluate response. Prostate size decreased in all participants, with average decrease of 27.3% and no adverse effects.